Literature DB >> 9572708

Autoantibodies and common viral illnesses.

K E Hansen1, J Arnason, A J Bridges.   

Abstract

OBJECTIVES: To review the literature about common autoantibodies produced in association with viral infection.
METHODS: Medline review of the medical literature published in English.
RESULTS: Common viral infections are often associated with low-titer, polyspecific autoantibodies. However, high-titer antinuclear antibodies, double-stranded DNA antibodies, anticardiolipin antibodies, and other subtype antibodies may be found. Hepatitis C and B virus, human immunodeficiency virus, and parvovirus B19 appear to be associated with autoantibodies more commonly than other viruses.
CONCLUSIONS: Transient autoantibodies resulting from viral infections are not uncommon. Clinical and laboratory follow-up over time will help distinguish between connective tissue disease and self-limited illness.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572708     DOI: 10.1016/s0049-0172(98)80047-4

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  25 in total

1.  Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infection.

Authors:  B S Tzang; T Y Chen; T C Hsu; Y C Liu; G J Tsay
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

2.  Peripheral blood B cell subset skewing is associated with altered cell cycling and intrinsic resistance to apoptosis and reflects a state of immune activation in chronic hepatitis C virus infection.

Authors:  Julia M Sugalski; Benigno Rodriguez; Susan Moir; Donald D Anthony
Journal:  J Immunol       Date:  2010-07-23       Impact factor: 5.422

Review 3.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  Presence of autoimmune antibody in chikungunya infection.

Authors:  Wirach Maek-A-Nantawat; Udomsak Silachamroon
Journal:  Case Rep Med       Date:  2009-11-25

Review 5.  Systematic review of case reports of antiphospholipid syndrome following infection.

Authors:  N Abdel-Wahab; M A Lopez-Olivo; G P Pinto-Patarroyo; M E Suarez-Almazor
Journal:  Lupus       Date:  2016-04-07       Impact factor: 2.911

6.  Anti-PCNA autoantibodies preferentially recognize C-terminal of PCNA in patients with chronic hepatitis B virus infection.

Authors:  T-C Hsu; G J Tsay; T-Y Chen; Y-C Liu; B-S Tzang
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

Review 7.  Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleys.

Authors:  Aikaterini Thanou; Joan T Merrill
Journal:  Nat Rev Rheumatol       Date:  2013-10-08       Impact factor: 20.543

8.  Prescription medication use and antinuclear antibodies in the United States, 1999-2004.

Authors:  Gregg E Dinse; Christine G Parks; Helen C S Meier; Caroll A Co; Edward K L Chan; Todd A Jusko; James Yeh; Frederick W Miller
Journal:  J Autoimmun       Date:  2018-05-18       Impact factor: 7.094

9.  The quest for autoreactive antibodies in nasal polyps.

Authors:  Els De Schryver; Lien Calus; Henryk Bonte; De Ruyck Natalie; Hannah Gould; Erin Donovan; Dirk Elewaut; Rudolf Valenta; Irene Mittermann; Jan Gutermuth; Tanja Seher; Robert P Schleimer; Bruce K Tan; Lara Derycke; Thibaut Van Zele; Claus Bachert; Philippe Gevaert
Journal:  J Allergy Clin Immunol       Date:  2016-05-06       Impact factor: 10.793

10.  Evaluating Comorbidities, Natural History, and Predictors of Early Resolution in a Cohort of Children With Chronic Urticaria.

Authors:  Elena Netchiporouk; Denis Sasseville; Linda Moreau; Youssef Habel; Elham Rahme; Moshe Ben-Shoshan
Journal:  JAMA Dermatol       Date:  2017-12-01       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.